For reasons that are not well understood, central nervous system repair in multiple sclerosis is often minimal. We present evidence, in a murine model of chronic progressive multiple sclerosis, that genetic factors can substantially influence remyelination, axonal integrity, and neurologic function. Four inbred mouse strains, SJL, B10.D1-H2 q , FVB, and SWR, developed extensive inflammatory demyelination by 3 months after infection with TheilerÕs murine encephalomyelitis virus. Demyelination continued lifelong in SJL and B10.D1-H2 q mice, accompanied by axonal injury, minimal remyelination, and progressive motor dysfunction. In contrast, FVB and SWR mice showed less axonal injury, progressive remyelination, and stabilization of motor function. Genetic dominance of the reparative traits was demonstrated by crossing remyelinating strains (FVB and SWR) with nonremyelinating strains (SJL and B10.D1-H2 q ). All F1 mice developed a phenotype identical to FVB and SWR, showing extensive remyelination, partial preservation of axons, and preserved motor function. Analyses of viral RNA and antigen, immune cell infiltration, and antiviral antibody titers did not predict the phenotypic differences between strains. These results highlight the significant extent to which hereditary factors can control disease course and demonstrate that the switch from a pathogenic to a reparative phenotype can occur even after prolonged inflammatory demyelination.
INTRODUCTION
Central nervous system (CNS) lesions in multiple sclerosis (MS) are characterized by demyelination, varying degrees of inflammation, oligodendrocyte death, axonal degeneration, complement activation, antibody deposition, and gliosis (1, 2) . In many MS patients, the development of lesions is accompanied by neurologic deficits that can follow an unpredictable pattern of remissions and relapses. Over time, the relapsing-remitting stage of the disease may progress to a course of irreversible neurologic disability. It has been suggested that the deficits observed during the relapsing-remitting phase of the disease may be due largely to the effects of inflammatory demyelination, while the irreversible neurologic disability seen in later stages may reflect progressive axonal loss (3) .
Spontaneous repair of MS lesions can occur and has most often been characterized by the presence of remyelination. Histologic studies describing remyelination in MS lesions were first reported over 30 years ago (4-6). Prineas et al confirmed these initial reports when they described remyelination in several patients with chronic MS lesions (7) . Nerve fibers with abnormally thin myelin sheaths and shorter than normal myelin internodes were observed at the margins of many of the chronic plaques that were examined, but the extent of the observed remyelination was extremely limited. In contrast, remyelination in acute lesions is often much more substantial. Remyelination exceeding 10% of total lesion area was found in over 20% of the lesions that were examined from 15 patients with early stage MS (8) . Numerous ''shadow plaques'' were also observed, which contained large numbers of thinly myelinated nerve fibers, suggesting that entire lesions had been remyelinated.
The strong remyelination response in acute MS lesions is reminiscent of remyelination following toxin-induced demyelination in animals (9) (10) (11) . Demyelination resulting from the injection of lysolecithin into the CNS is rapidly and completely remyelinated with myelin sheaths that are uniformly thinner than normal and with characteristically shorter myelin internodes. Remyelination is also a prominent feature following recovery from murine hepatitis virus (MHV)-induced demyelination in mice (12, 13) . In the MHV model, demyelination follows initial virus infection and is accompanied by the development of ataxia and paralysis. Recovery of functional deficits is mediated by remyelination that begins as early as 14 days postinfection. The significant remyelination observed in some MS lesions and in some animal models of demyelinating disease demonstrate that nearly complete myelin repair is possible, although often limited to early disease stages.
Axonal injury and loss can be significant in some MS lesions, and remyelination has the potential to protect axons (14) .
Remyelination can restore the saltatory conduction of action potentials and may contribute to remission of neurologic deficits (15) (16) (17) (18) . In contrast, remyelination failure not only affects conduction but also likely makes axons more susceptible to secondary injury and loss. Understanding the mechanisms that regulate pathogenesis versus repair is essential for developing therapeutic strategies for the management of MS.
Toward this goal, we have investigated the genetic regulation of demyelinating disease following TheilerÕs virus infection. Infection of SJL (SJL/J) mice results in chronic inflammatory demyelination, axonal loss, minimal remyelination, and progressive neurologic deficits. In this report, we compare SJL mice to several other inbred and hybrid mouse strains to elucidate the extent to which hereditary factors influence disease course. Two inbred strains, FVB (FVB/NJ) and SWR (SWR/J), show extensive spontaneous remyelination with axonal and functional preservation, which follows a period of progressive demyelination. Moreover, we demonstrate that this ''reparative phenotype'' is inherited as a dominant and highly penetrant genetic trait. Elucidation of the molecular basis for the reparative phenotype may be possible through further genetic analyses of these strains and may suggest potential targets for therapeutic intervention in human MS.
MATERIALS AND METHODS

Mice and Viral Infection
SJL/J, FVB/NJ, SWR/J, and B10.D1-H2 q /SgJ (B10.Q) mice were obtained from Jackson Laboratories (Bar Harbor, ME). F1 hybrid mice were bred at the Mayo Clinic. Sixto eight-week-old mice were injected intracerebrally with 2.0 3 10 6 plaque-forming units (pfu) of the DanielÕs strain of TheilerÕs murine encephalomyelitis virus (TMEV). All animal protocols were approved by the Mayo Institutional Animal Care and Use Committee.
For ease in the comparison of different groups of animals, references to the duration of virus infection for a given group is generally given to the nearest number of months postinfection at the time of assessment. While this is usually an estimate, for any specific group the actual time postinfection is within 610% of the time listed.
Pathology Analyses
Quantitation of inflammatory demyelination and remyelination was conducted on cross-sections of spinal cord, as previously described (19) . Briefly, mice were anesthetized with an overdose of sodium pentobarbital and tissues were fixed by intracardiac perfusion of TrumpÕs fixative (phosphate-buffered 4% formaldehyde with 1% glutaraldehyde, pH 7.4). Spinal cords are removed and cut into 1-mm blocks; every third block was postfixed and stained with osmium tetroxide, and embedded in araldite plastic (Polysciences, Warrington, PA). One-micrometer-thick cross-sections were cut from each block and stained with 4% p-phenylenediamine to visualize the myelin sheaths in spinal cord white matter.
The total white matter area, total area of demyelinated pathology, and area of remyelination were quantified from 8 to 10 sections per spinal cord, spanning spinal cord levels C2-L3, using a Zeiss interactive digital analysis system (ZIDAS), as previously described (9, 19) . Lesion load was represented as the total area of demyelination (including remyelinated areas) from the 8 to 10 sections that were analyzed from each cord, expressed as a percentage of the total white matter area.
Regions showing significant remyelination were similarly quantified, and the remyelinated area was expressed as a percentage of the total lesion area. Oligodendrocyte-mediated remyelination was characterized by abnormally thin myelin sheaths, usually around the edges of the lesion, whereas Schwann cell-mediated remyelination was characterized by abnormally thick myelin sheaths with dispersed axon-myelin profiles.
Motor Function Analysis
Motor function was assessed using a Rotamex Rotarod (Columbus Instruments, Columbus, OH) for the assessment of coordination and strength (20) . Mice were first trained on 3 consecutive days, for three, 3-minute periods at a fixed rotor speed, to teach them to maintain balance and to run on the rod. The system is also equipped with an electrified floor grid that serves as an aversion stimulus to train the mice to remain on the rod. Neurologic function was then assessed in an accelerated rotarod experiment. The test begins when a mouse is placed on the stationary rod and the rod is then accelerated at a rate of 5 rpm/min over 7 minutes to a maximum rate of 40 rpm. The test ends when the mouse falls off the rod onto the underlying grid, and the latency to fall and the rod speed at the time of the fall are recorded. At each time point, the mean duration on the rod (performance) was determined from three trials for each mouse, and the average performance of groups of 4 to 10 mice from each strain was defined as a measure of neurologic ability. Generally, performance was measured prior to infection (baseline) and during the course of disease; the data were then expressed as percentage change from baseline performance to normalize for interstrain differences in performance.
Retrograde Neuronal Labeling
Retrograde labeling of descending neurons was performed as previously described (21, 22) by implanting Gelfoam sponge (Upjohn Company, Kalamazoo, MI) soaked in Fluoro-Gold (4% in sterile PBS; Fluorochrome, Inc., Englewood, CO) into the hemisected spinal cord at the T12 level of the spinal cord, in mice anesthetized with sodium pentabarbital (0.07 mg/g mouse weight). Mice were killed for analysis 7 days later by intracardiac perfusion with 4% paraformaldehyde. Retrogradely labeled neuronal cell bodies were visualized by UV epifluorescence in 30-mm vibratome sections. Reticulospinal and raphespinal neurons in the brainstem were quantified under a 403 objective in 10 sections with 90-mm spacing between sections, spanning 1.1 mm in total. The junction of the brainstem and cerebellum served as a stereotactic landmark (interaural 22.44) (23), where the highest density of labeled neurons was located. Five sections rostral and 5 sections caudal to the landmark were analyzed. All labeled cell bodies on the right side of each section (ipsilateral Fluoro-Gold application) were counted on coded samples, and without knowledge of the experimental group.
Real-Time RT-PCR Quantitation of RNA
Total RNA was isolated from spinal cord-plus-brainstem homogenates using RNA STAT-60 (Tel-Test, Inc., Friendswood, TX) and stored at 280°C. Levels of specific RNA were determined by real-time reverse transcription-polymerase chain reaction (RT-PCR) using a LightCycler Instrument and LightCycler SYBR I RNA Amplification Kit (Roche Diagnostics, Mannheim, Germany). RNA levels were measured for the viral capsid protein, VP2, and for murine glyceraldehyde-3-phosphate dehydrogenase (GAPDH), using the following primers at 0.5 mmol/L: VP2 forward 5#-TGGTCGACTCTGTGGTTACG-3#; VP2 reverse 5#-GCCGGTCTTGCAAAGATAGT-3#; GAPDH forward 5#-CCATGTTTGTGATGGGTGTG-3#; GAPDH reverse 5#-GA-TGCAGGGATGATGTTCTG-3#. Ten nanograms of total sample RNA was used in each reaction, an amount found in titration experiments to be optimal for detecting differences in specific RNA levels. Reaction conditions were as follows: reverse transcription, 55°C for 10 minutes; denaturation, 95°C for 1 minute; amplification (35 cycles), 95°C for 1 second + 62°C for 7 seconds + 72°C for 15 seconds; melt 0.1°C/second. Reaction controls included water alone or experimental samples made through mock RNA isolation (tissue excluded). No specific reaction product was amplified in control reactions, as indicated by melting curves. Experimental samples that gave reaction products with melting peaks lower than those expected (e.g. water reaction) were considered below the limit of detection. The lower limits of detection were 5 3 10 4 copies for VP2 and 10 6 copies for GAPDH. Plasmids containing the complete cDNA sequences for VP2 and GAPDH were used as standards for quantification. Standards were amplified with the same reaction mixtures and conditions as the experimental samples and had linear product-cycle regressions over a 5-log range of input plasmid, and single melting peaks corresponding to calculated melting temperatures.
Viral Antigen Quantitation
Using the same spinal cords that were used for pathology analyses, ten 1-mm blocks from each spinal cord were embedded in paraffin and cross-sections collected for immunostaining. Viral antigen was detected using polyclonal rabbit antiserum raised against purified TheilerÕs virus, followed by biotinylated anti-rabbit IgG secondary antibody and ABC reagent (Vector Laboratories, Burlingame, CA). The number of cells that were positive for viral antigen were counted and expressed relative to the total spinal cord crosssectional area.
Inflammatory Cell Analysis
Spinal cords and brainstems from pairs of chronically infected mice (pairs were used to increase cell yields) were homogenized in cold RPMI medium in a Tenbroek glass homogenizer. Homogenates were mixed 2:1 (v/v) with Percoll (Amersham-Pharmacia), and viable cells were collected after centrifugation at 15,000 rpm for 30 minutes. Red blood cells were lysed with ACK buffer (155 mmol/L NH 4 Cl, 10 mmol/L KHCO 3 , 0.01 mmol/L EDTA), the cell suspension was washed twice, and viable cells were counted (. 90% viable). Fluorescence-tagged primary antibodies directed against CD45, CD11b/Mac-1, B220/CD45R, CD8, CD4, CD44, and CD69 were purchased from BD Pharmingen (San Diego, CA) and diluted in HBSS + 1% BSA + 0.05% azide for surface staining. Cells were stained on ice for 45 minutes, washed twice, and analyzed by flow cytometry.
Antiviral Antibody Analyses
Antiviral antibodies in serum from infected mice were analyzed by enzyme-linked immunosorbent assays (ELISA) and by virus neutralization assay. For ELISA, microtiter plates were coated overnight with TMEV (10 5 pfu/mL) in carbonate buffer, pH 9.5, and blocked with 5% (w/v) nonfat milk. Plates were subsequently incubated with serum diluted in PBS + 0.1% nonfat milk, followed by biotinylated secondary antibodies and streptavidin-alkaline phosphatase (Jackson Immunoresearch, West Grove, PA; Vector Laboratories). Between reagent incubations, plates were rinsed with PBS + 0.05% Tween 20. For virus neutralization assays, aliquots of 200 pfu of TMEV were preincubated with twofold serum dilutions for 1.5 hours, then placed on confluent monolayers of L2 cells for 1 hour. Cells were overlaid with medium plus 0.2% SeaPlaque agarose (FMC Bioproducts, Rockland, ME). Data were expressed as the serum dilution needed to neutralize 75% of viral plaque-forming ability.
Statistics
All statistical comparisons were made by nonparametric Mann-Whitney rank sum tests. p values of less than 0.05 were considered to indicate statistical significance. Variances are reported as standard errors of the mean.
RESULTS
Late Onset Remyelination in FVB and SWR Mice
The DanielÕs strain of TheilerÕs virus induces inflammatory demyelination of the spinal cord and brainstem in susceptible strains of mice. In SJL mice, the most commonly used inbred strain, demyelination begins 2 to 3 weeks postinfection, largely as an immunopathologic response to virus. Demyelination increases over the next 2 to 3 months and maintains a steady level thereafter. Axonal damage ensues and mice develop progressive neurologic deficits. Remyelination is largely absent at any point during the disease. In the present study, we have characterized the disease in three strains of inbred mice in addition to SJL (see Materials and Methods section for exact strain designations). Two strains, FVB and SWR, are similar in ancestry to SJL mice (24) but are of a different haplotype than SJL at the major histocompatibility complex (MHC H-2 locus). SJL have an H-2 s haplotype, whereas FVB and SWR are H-2 q . The third strain, B10.Q, is a C57BL strain that is congenic for H-2 q . This strain represents an important control for SWR and FVB mice because the H-2 locus regulates susceptibility to disease (25) (26) (27) (28) (29) (30) . Inflammatory demyelination developed in all four strains upon infection with virus and was qualitatively similar at 3 months postinfection. Spinal cords contained abundant lesions with extensive demyelination (Fig. 1) . In all strains, lesions occurred most frequently in the lateral and ventral columns of the thoracic and cervical cord.
Beyond 3 months postinfection, the pathology among the strains diverged. SJL and B10.Q maintained the typical demyelinated pattern for as long as 1 year, with little remyelination. In contrast, FVB and SWR mice developed extensive remyelination (Fig. 1F, H) . Remyelination was generally oligodendrocyte-mediated, characterized by abnormally thin myelin sheaths. However, 10% to 15% of remyelination was Schwann cell-mediated, characterized by more dispersed myelin profiles, abnormally thick myelin sheaths, and juxtaposed cell bodies. By 1 year postinfection, many lesions showed nearly complete remyelination, sometimes making it difficult to demarcate the original lesions from normal white matter.
The extent of lesions (lesion load) and remyelination in each strain were quantified morphometrically in a series of spinal cord cross-sections (10 sections/cord) spanning spinal cord levels C3-L3 (Table) . On average, 11.0 6 2.8% (n = 7) of the white matter was demyelinated in SJL mice at 3 months postinfection and 9.0 6 1.4% (n = 7) at 11 months. Lesion load was somewhat less in FVB mice, 4.2 6 1.1% (n = 5) at 3 months postinfection and 7.6 6 2.3% (n = 6) by 11 months, although the differences in lesion load between SJL and FVB were not significant at any time point (3 months, p = 0.07; 11 months, p = 0.63). Small but significant amounts of remyelination occur in SJL mice between 3 and 11 months postinfection (p , 0.001), reaching a maximum of 10.9 6 3.1% (n = 7) at 11 months postinfection (Table; Fig. 2 ). In contrast, remyelination increased dramatically between 3 months and 11 months postinfection in FVB mice. By 11 months postinfection, an average of 69.0 6 5.3% (n = 6) of lesion area was remyelinated in the FVB strain (Table; Fig. 2 ). The extent of remyelination at 11 months postinfection in FVB mice was statistically greater than that observed in SJL mice at 11 months (p = 0.001).
The lesion loads in SWR and B10.Q mice were similar to those observed in FVB and SJL. SWR mice showed extensive remyelination at both 7 and 11 months postinfection (41.5 6 6.4%, n = 6 and 68.4 6 9.9%, n = 4, respectively), whereas B10.Q showed very little remyelination, reaching only 8.9 6 3.2% (n = 4) by 11 months.
Neurologic Function Is Preserved in FVB and SWR Mice
Neurologic disease was assessed by qualitative observation and by rotarod analysis of motor function. All four strains showed a similar phenotype in the first 3 months postinfection. At approximately 1 week postinfection, they became transiently lethargic due to acute encephalitis that develops in response to viral infection. This stage of disease lasted for 1 to 2 weeks, after which the mice recovered. They retained normal activity and appearance until 3 to 4 months, beyond which the functional phenotypes diverged. SJL and B10.Q mice developed progressive neurologic dysfunction. It began as a reduction in spontaneous activity and progressed over several months, as indicated in these mice by difficulty in righting themselves when rolled onto their back, waddling gait, spasticity, and paralysis. In contrast, we observed few clinical signs of disease in FVB or SWR at any time up to 1 year postinfection.
Neurologic function was further assessed by an accelerated rotarod assay, an objective measure of motor function (20) . Rotarod performances by SJL and FVB mice were compared at several time points postinfection (Fig. 3A) . In all strains of mice that we have tested, there is an initial and permanent decline in rotarod performance of 20% to 30% of the uninfected baseline performance during the acute phase (first 30 days) of the disease. This decline precedes the appearance of spinal cord lesions and is likely due to damage from viral infection in the brain. In Figure 3A , we have therefore defined baseline performance as performance at 34 days postinfection. Figure 3A shows that motor function in SJL mice declines steadily from 34 to 265 days postinfection, whereas FVB rotarod performance declines very little during 
Remyelination and Preservation of Neurologic Function Are Genetically Dominant
An important long-term goal of this research is to determine what genetic mechanisms control remyelination and preservation of neurologic function. Toward this goal, we examined the mode of inheritance of CNS repair by crossing FVB and SWR mice with SJL and B10.Q mice to generate (FVB 3 SJL)F1, (FVB 3 B10.Q)F1, and (SWR 3 SJL)F1 hybrid mice. Infected mice of all three crosses developed demyelinated lesions, followed by extensive remyelination with a time course similar to that observed in the FVB and SWR parental strains (Fig. 4) . As in the parental strains, most remyelination was oligodendrocyte-mediated, although significant (10%-15%) Schwann cell-mediated remyelination was also observed.
Lesion load and remyelination were quantified morphometrically in the F1 hybrids. (FVB 3 SJL)F1 mice had similar lesion loads compared with the parental FVB strain at 11 months postinfection (4.0 6 0.6%, n = 9 vs 7.6 6 2.3%, n = 6; p = 0.38; Table) . Like the FVB parental strain, these mice showed extensive remyelination at 11 months postinfection (68.5 6 4.0%, n = 9; Table; Fig. 2 ). (FVB 3 B10.Q)F1 and (SWR 3 SJL)F1 hybrid mice also showed extensive remyelination, 39.1 6 6.6% (n = 8) and 29.0 6 6.4% (n = 9), respectively, at 7 months postinfection. Compared with SJL mice, the extent of remyelination was statistically greater in (FVB 3 SJL)F1 mice at 11 months postinfection (p = 0.001), and in (SWR 3 SJL)F1 mice (p = 0.002) and (FVB 3 B10.Q)F1 mice (p , 0.001) at 7 months postinfection.
All three F1 populations appeared clinically normal at time points up to 1 year postinfection. Rotarod performances were assessed at 11 months postinfection for FVB, B10.Q, and (FVB 3 B10.Q)F1 mice with performance expressed as a percent of the baseline performance of a matching control group of sham infected mice (Fig. 3B) . Although the (FVB 3 B10.Q)F1 hybrid mice appeared clinically normal throughout the experiment, rotarod performance did show a marginally significant decrease in performance at 11 months postinfection compared to the FVB parental strain (p = 0.050). Performance of the B10.Q parental strain was significantly reduced compared to both FVB and (FVB 3 B10.Q)F1 mice (p = 0.004 for both comparisons).
Axonal Integrity Is Partially Preserved in SWR and (SWR x SJL)F1 Mice
Histologic observations suggested that there was more axonal loss in SJL mice than in remyelinating strains. The superior neurologic function of SWR, FVB, and F1 hybrid mice may therefore be due not only to remyelination and improved conduction, but also due to more axonal preservation in these strains. To test this possibility, we conducted retrograde neuronal labeling of descending reticulospinal neurons using the fluorescent tracer, Fluoro-Gold (21, 22) . This tracer is taken up nonspecifically by axons and transported in lysosomal vesicles that accumulate in neuronal cell bodies. Fluoro-Gold was administered to the spinal cord at the T12 level in SJL, SWR, and (SWR 3 SJL)F1 mice, and cell body labeling was assessed 7 days later. Since pathology occurs in the cervical and thoracic cord, reductions in the number of labeled cell bodies reflect either sustained dysfunction in retrograde transport or, more likely, axonal degeneration (31) . Quantitation was performed by counting labeled cell bodies in a series of 10 sections from each brainstem.
Uninfected SJL and SWR mice showed identically high levels of labeling (Fig. 5) . In contrast, chronically infected SJL mice (9-13 months postinfection) showed a 72% reduction in the number of labeled cell bodies, and the neurons that were labeled had weak fluorescence. Chronically infected SWR and (SWR 3 SJL)F1 mice also showed reduced numbers of labeled cell bodies, but the reduction was significantly less extensive than in infected SJL mice (46%, p = 0.042) and overall fluorescence was stronger. Thus, axonal injury occurred in all strains but was less pronounced in mice with preserved neurologic function and remyelination. These results also demonstrate that axonal preservation, like remyelination, was inherited as a dominant trait.
Virus Persists in the Spinal Cord of Strains That Show Extensive CNS Repair
A possible explanation for the enhanced remyelination and the preservation of neurologic function in FVB and SWR mice is that virus levels, and consequently antiviral immune responses, have subsided sufficiently to allow spontaneous remyelination and the return of normal physiologic function. Therefore, we measured virus from infected spinal cord tissue in three ways: infectious virus was quantified by plaque assay, levels of viral capsid RNA were measured by real-time RT-PCR, and viral antigen expression was assessed by immunohistochemistry. Spinal cord homogenates (four separate cords each from SJL and FVB) were tested for infectious TMEV at 8 months postinfection, but no infectious virus was detected in any of the samples. Purified virus used for mouse infection served as the positive control. The absence of infectious virus at this late time point is consistent with previous observations (32, 33) and suggests that viral RNA or protein, rather than infectious virions, sustains antiviral responses late in disease.
RNA levels for the viral capsid protein, VP2, and for the housekeeping enzyme, GAPDH, were quantified by real-time RT-PCR in SJL, FVB, and (FVB 3 SJL)F1 mice. The level of VP2 ranged from 4.9 to 7.0 logs of viral RNA for all infected strains, with a lower limit for detection at about 4.4 logs of viral RNA. Viral RNA levels were expressed as the ratio of log VP2 RNA/log GAPDH RNA (Fig. 6A) . At 3 months postinfection, near the onset of remyelination, we found similar levels of VP2 RNA in SJL and FVB mice (p = 0.09). At 9 months postinfection, FVB mice had less VP2 RNA than SJL (p = 0.001). Importantly however, (FVB 3 SJL)F1 mice had equivalent levels to SJL (p = 0.41), suggesting that low VP2 RNA levels were not a prerequisite for efficient remyelination.
The number of infected, virus antigen-positive cells correlates with lesion load in SJL mice and is therefore a potentially relevant measure of virus burden (34) (35) (36) ). An analysis of antigen-positive cells at 7 to 11 months postinfection in SJL mice and in strains that show spontaneous repair (FVB, SWR, [FVB 3 SJL]F1, and [SWR 3 SJL]F1 mice) revealed no significant difference in the number of virus-antigen positive cells between strains that repair and those that do not (Fig. 6B) . SJL mice had an average of 3.5 positive cells/mm 2 of spinal cord, whereas repairing strains had 2.3 cells/mm 2 (p = 0.09). We observed remyelination in FVB, SWR, (FVB 3 SJL)F1, and (SWR 3 SJL)F1 mice in association with both low or high numbers of virus antigenpositive cells; conversely, SJL mice failed to remyelinate efficiently even at low levels of virus expression. Therefore, the data do not support the hypothesis that efficient repair was a secondary consequence of virus clearance.
CNS Repair Does Not Correlate with Levels of Neutralizing Antiviral Antibody
Antiviral antibodies may play an important role in limiting viral spread and consequently reducing immune cell activation and CNS injury. Therefore, we assessed TMEVspecific antibody titers in sera from infected FVB, SWR, and SJL mice. ELISA assays against purified TMEV revealed that antiviral antibody levels in SJL mice at 1.5 months postinfection were elevated 15.2 6 0.6-fold (n = 4) over the binding of antibody from uninfected control mice. This level decreased over time to 7.0 6 1.0-fold (n = 6) at 8 months postinfection. SWR mice showed a similar pattern. Levels in FVB mice were also increased at 1.5 months to 4.2 6 0.3-fold (n = 4) over controls, and increased slightly to 5.1 6 0.1-fold (n = 5) at 10 months postinfection. We also used plaque assay to determine the TMEV neutralization efficiencies of sera from FVB, SWR, and SJL mice at 7 to 12 months postinfection. Sera from all strains were similarly effective, showing 75% neutralization at median dilutions of 6,400-fold for FVB, 6,400-fold for SJL, and 13,440-fold for SWR. Thus, neither antiviral antibody level nor viral neutralization efficiency was consistently or appreciably higher in the remyelinating strains, arguing against a role for humoral antiviral immunity in the induction of remyelination.
Chronic CNS Inflammation Continues through the Onset of CNS Repair in FVB and SWR Mice
Virus persistence during late disease, even in mouse strains that exhibit CNS repair, suggests that CNS Inflammatory cells were identified, and their relative proportions determined by flow cytometry, using antibodies directed against CD45 (a marker for hematogenous cells and microglia), CD11b/Mac-1 (macrophages, microglia, and T lymphocytes), B220/CD45R (B cells), CD8 (T cell subset), CD4 (T cell subset), CD44 (activated, migratory cells), and CD69 (early T cell activation). The percentage of each cell type was highly consistent among individuals within each strain for most of the markers (Fig. 7A, B) . The majority of isolated cells were CD45-positive, representing approximately 80% of cells at 2 months postinfection and 70% of cells at 6 months postinfection. Two notable differences between SJL and FVB at 2 months postinfection were the proportions of B220-positive and CD69-positive cells. A higher proportion of SJL cells were B220-positive compared with FVB (73% vs 27%; p = 0.006). In contrast, fewer cells expressed CD69 in SJL than in FVB (4% vs 19%; p = 0.014), suggesting more T cell activation in the FVB strain (37) (38) (39) (40) . Consistent with this interpretation, we also observed a trend toward more CD44
high -positive cells in FVB compared with SJL (39% vs 26%, p = 0.07), implying a greater capacity for infiltration and/or migration in the CNS (41, 42) . Relative levels of CD4 and CD8 T cells did not vary significantly among strains at 2 months postinfection.
At 6 months postinfection, SJL and FVB mice no longer differed in the relative degree of B220 staining (Fig. 7B) . Instead, SJL had more CD4 cells (18% vs 10% in FVB; p = 0.004) and CD8 cells (10% vs 7% in FVB; p = 0.034). CD11b-positive macrophages or activated microglia were highly abundant in both strains of mice, both early and late in disease. In summary, significant CNS inflammation continues for at least 6 months postinfection, both in strains that repair and in those that do not.
DISCUSSION
The FVB and SWR strains of mice represent a unique model of demyelinating disease following TheilerÕs virus infection in which protective and reparative mechanisms ultimately supersede pathogenesis, resulting in significant myelin repair and axonal preservation. Unlike SJL or B10.Q mice, which developed chronic demyelination, minimal remyelination, and progressive disability, FVB and SWR strains showed a reversal of disease characterized by extensive remyelination with axonal and functional preservation. By 11 months postinfection, these mice show an average of 70% remyelination of previously demyelinated area, compared with about 10% in SJL and B10.Q. Axonal preservation accompanied remyelination in FVB and SWR mice as demonstrated by preserved neurologic function and by reduced axonal loss as measured by retrograde labeling of reticulospinal neurons. This ''reparative phenotype'' is highly penetrant and is dominantly inherited in outcrosses with nonremyelinating mice. Why does remyelination fail in the SJL and B10.Q strains but proceed robustly in FVB and SWR mice? Unique immune responses in SWR and FVB mice compared with SJL and B10.Q offer a possible explanation for the repair, but our data did not reveal major differences between FVB and SJL late in disease. Our analyses demonstrated long-term CNS inflammation in all strains, irrespective of whether or not the mice acquired a reparative phenotype. Macrophage/microglial activation was robust and equivalent in SJL and in remyelinating strains at early and late time points, and CD4 and CD8 infiltration differed only minimally at 6 months postinfection. Differences in B or T lymphocyte activation early in disease provide potential clues for future investigations.
The hypothesis that remyelination can be influenced by the inflammatory response is reinforced by previous findings in the TheilerÕs virus model. First, immunosuppression with cyclophosphamide or lymphocyte-depleting antibodies promotes remyelination in chronically infected SJL mice (36) . Second, PLJ mice that are genetically deficient in CD4 cells go on to remyelinate and recover neurologically if they survive the initial stages of infection (43) . Finally, mice with a genetic deletion of b2-microglobulin, and therefore deficient in Class I MHC-restricted CD8 T cells, also exhibit extensive spontaneous repair and minimal neurologic deficits (22, 44) . These studies show precedence for both CD4 and CD8 T lymphocytes in restricting remyelination and in the present study both of these subsets were quantitatively lower in FVB than in SJL late in disease.
Although the immune response undoubtedly plays a central role in disease development in all strains, there are no clear data to suggest that the quality of the immune response differs significantly between the strains, and the ability to restore normal structure and function may be more dependent upon the properties of endogenous CNS cells than with the inflammatory response. For example, oligodendrocytes or their precursors may be more resistant to damage or may have more robust, regenerative potential in remyelinating strains. Another possibility is that axons are more resistant to immune-mediated injury. The preservation of axonal integrity in strains that show significant repair, as indicated by retrograde labeling, strongly suggests that reduced susceptibility to axonal damage is an important part of the reparative phenotype. More surviving axons would provide a stimulus for greater remyelination, which in turn would serve as the basis for preserved neurologic function.
Our data indicate that clearance of viral RNA and protein was not necessary for repair to occur. Although VP2 RNA and viral antigen were slightly reduced in FVB and SWR mice late in disease course, this did not hold true for F1 hybrid mice. Moreover, comparisons of mice with nearly identical numbers of virus infected cells showed marked differences in remyelination between strains. We cannot rule out the possibility that the lower virus expression in some of the strains late in disease course may have been beneficial. However, our data do not support the hypothesis that low virus expression was a prerequisite for the CNS repair.
The delay in onset of remyelination is a unique feature of this model of CNS repair. In mice infected with neurotropic strains of MHV, remyelination begins at approximately 3 weeks postinfection, shortly after clearance of infectious virus and the onset of demyelination (13, 45) . Remyelination also develops rapidly in some nonviral models of demyelination. It begins within a week of removal of the myelin toxin, cuprizone, from the rodent diet (46) and within 2 weeks following demyelination induced by lysolecithin (9) . In the model presented here, remyelination is not significant in the SWR and FVB strains until approximately 3 months postinfection and well after the development of significant demyelination. Remyelination then continues to increase for 7 to 8 months. The delayed onset and slow progression of the repair probably indicates that the process is complex and dynamic, but details about the molecular nature of the process remain to be determined.
Genetic analyses have been useful in searching for loci that contribute to disease susceptibility in MS and in the most common animal models of MS: experimental autoimmune encephalomyelitis and TheilerÕs virus-induced inflammatory demyelination (47) (48) (49) (50) (51) . There has been relatively little genetic analysis on the process of remyelination. Our findings demonstrate that morphologic and functional recovery from disease is strongly regulated at the genetic level and is inherited as a dominant trait. Crosses of FVB and SWR mice with two different, nonrepairing mouse strains, SJL and B10.Q, show highly penetrant and dominant inheritance of remyelination, axonal protection, and preservation of neurologic function. This model for CNS repair should provide an excellent opportunity to use genetic analysis to define the molecular mechanisms of myelin repair and axonal preservation.
